Join Us for NeuroNexus 2024
Dates: November 16-17, 2024
Event Format:
- Day 1 (November 16) – Online Only
Fully virtual day with keynote sessions, presentations, and poster sessions. - Day 2 (November 17) – Hybrid Event
Join us in person at Alte University or online. Activities include workshops, keynote sessions, and networking opportunities.
Conference Duration:
7-8 hours each day
Registration Details:
Phase 2 Registration (October 20 – November 12, 2024)
Register here
- Audience (Online): $5 USD
- Participants (Online/Offline): $20 USD
Why Attend NeuroNexus?
Keynote Speakers:
Insights from international speakers.
Collaborations:
Network with reputable international organizations such as IJSRI, GIMSOC, Medignite, Research Insights, and others.
Activities:
Participate in quizzes, presentations, and discussions. Prizes for top performances.
Research Presentation Opportunity:
Present your research, and all accepted abstracts will be published in the International Journal of Medical Students Research & Innovation (IJMSRI).
Networking:
Connect with professionals from around the world.
Special Announcement
All accepted abstracts will be published in IJMSRI.
Affiliation:
This event is affiliated with Alte University, Tbilisi, Georgia.
Benefits for Participants
- CPD accreditation (16 points)
- Digital presentation certificates
- Certificates of excellence for top performers
- Publication opportunity for top winners
- Abstract publication in IJMSRI
- Digital attendance certificate
- IJMSRI vouchers and digital goodies
Benefits for Audience
- CPD accreditation (16 points)
- Attendance certificate
- IJMSRI vouchers and digital goodies
Abstract Submission
Email: submission.medventures@gmail.com
Deadline: November 10, 2024
Expect a response within 2 days confirming if your abstract is accepted or declined.
Note: Please follow the abstract guidelines carefully.
Contact Information
- General Inquiries: Instagram @med.ventures_
- Registration/Payment Issues: help.medventures@gmail.com
We look forward to seeing you at NeuroNexus 2024.
